Sanofi Plans €1.5 Billion mRNA Vaccine Plant in France
Sanofi announced a €1.5 billion investment in a new messenger RNA vaccine manufacturing facility in the Auvergne-Rhône-Alpes region, supported by the French government as part of efforts to strengthen domestic medical supply capacity.